Health
Sanofi’s mRNA COVID-19 vaccine candidate not ready this year, CEO says – Reuters
A COVID-19 vaccine candidate developed by Sanofi and U.S. group Translate Bio “will not be ready this year,” the French drugmaker’s chief executive told Le Journal…
By Reuters Staff
PARIS (Reuters) – A COVID-19 vaccine candidate developed by Sanofi and U.S. group Translate Bio will not be ready this year, the French drugmakers chief executive told Le Journal du Dimanche newspaper.
FILE PHOTO: Paul Hudson, Chief Executive Officer of Sanofi, delivers a speech after a visit at the French drugmaker’s vaccine unit Sanofi Pasteur plant in Marcy-l’Etoile, near Lyon, France, June 16, 2020. REUTERS/Gonzalo Fuentes/Pool
Clinical trials of this vaccine, which will be…
-
Business19 hours agoTop brokers name 3 ASX shares to buy next week 25 May 2025
-
Noosa News13 hours agoFears for the future of retro Chinese dining after blaze guts Sundoo in Townsville
-
Business16 hours agoThese ASX 200 shares could rise 20% to 100%
-
General15 hours agoAustralia’s native flora emerges as an increasingly popular muse for bonsai hobbyists